OTEIA MORRIS: Open Payments
NPI 1710431226 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 13 payments from 9 companies in 2025. Trend: 2023 $741 · 2024 $725 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $213 |
| Lilly USA, LLC | 3 | $164 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Corcept Therapeutics | 1 | $29 |
| Rhythm Pharmaceuticals, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| BETA BIONICS, INC. | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| VIVUS LLC | 1 | $21 |
Products named: Wegovy, ZEPBOUND, JOURNAVX, Korlym, IMCIVREE, MOUNJARO, GVOKE HYPOPEN, iLet Bionic Pancreas.
Industry payments across GA — which companies pay providers there.
